Memory and Tolerance Flashcards
Characteristics of immunological memory?
Secondary response - greater and more rapid, plus higher affinity
Stages of immunological memory?
Expansion of clonal cells (with specific antigen receptor genes)
Enhanced migration and restimulation
Survival of clones
Memory B cells?
All immunoglobins on membrane, plus complement receptors
Found in bone marrow, lymph node and spleen
High ICAM-1 for adhesion and migration
B cells have already proliferated but not differentiated to plasma cells - still need CD4 Ths
Effector T cells in memory?
CD4
Produce survival factors and cytokines, plus have surface proteins for adhesion, chemokines and activation markers
Assist B and CTLs, plus macrophages
CD8
May form killer cells
Pathways for memory T cell generation?
A. Divergent pathway, like B cells - T cell diverge to effector cells (with Ag) or memory cells
B. Linear Development
Naive cell – effector with Ag – loss of Ag = memory cell
Maintaining memory T cells?
Mediated by IL15 and IL17 cytokines driving homeostatic proliferation, capable of maintaining populations for decades
AICD?
Activation induced cell death - manner in which activated T cells are fated for death to avoid inflammation
Basis of vaccination?
Generating memory responses (hallmark of adaptive immunity) in absence of serious illness
What is required for a vaccine?
Antigens
Infection signal to stimulate immune system (often provided by adjuvant if only antigen is given)
Types of vaccine?
Live attenuated Killed/inactivated Protein subunit Recombinant viral-vectored Virus-like particles Nucleic acid-based
Live attenuated vaccines?
- related, less harmful pathogen
2. attenuated pathogen i.e. weakened - better
Killed/inactivated infection?
e.g. polio vaccine
Lower risk of disease - may need boosters
Cultivation of pathogen, inactivator e.g. irradiation added
Protein subunit vaccines?
Purified/recombinant agents to mimic antigen, picking those that are best for stimulating the immune system
Need a booster
Recombinant viral-vectored vaccines?
Viruses engineered to express pathogen antigens in vivo - safe, widely used
Virus like particles?
Non-infectious particles mimic the pathogen - very effective, can be engineered with multiple antigens to mimic mutations
Nucleic acid based?
Can encode the antigens, delivered to cells via carrier, cells then express the antigens
How can vaccines be improved?
Use of adjuvants to stimulate the immune system, e.g. oil/water emulsions, aluminium based TLR liganeds, liposomes
Can cause issues like septic shock, autoimmunity
MHCs
Not all antigens invoke an immune response - multivalent vaccines with many epitopes target all MHCs
Where do vaccines fail?
Where we lack natural immunity e.g. malaria, HIV, TB
These are also latent, so vaccines will not always induce a response
Why do we lack vaccines?
Lack of understanding of pathogen life cycles
May not know the antigens
Antigens may vary e.g. mutators
Lack of good lab models as natural versions hard to find
Transport, storage and costs
Research gaps - neglect tropical diseases (more with climate change)
Vaccine hesitancy? Case study?
MMR vaccine and autism Samoa measles outbreak Themes include: Control (body autonomy) Parenting style Past issues Risk of vaccine vs disease not understood Fear of chemicals Distrust of gov/corporations
Herd immunity?
1 unvaccinated individual in Samoa caused the catastrophic measles outbreak
Threshold depends on pathogen virulence and susceptibility
What is central tolerance?
Negative selection of self-recognising T and B cells to avoid autoimmunity
Why do we need tolerance?
Self - avoid attacking own cells
External - avoid attacking harmless non-self cells e.g. fetomaternal antigens, allergic reactions, transplants, commensal gut bacteria
Original explanations for self tolerance?
Found to be aquired, not inherited, through twin studies which share a blood supply
Thought to be due to clonal deletion - immature cells that encountered antigens would die. However, this would = holes in our repertoire i.e. loss of our broad non-specific range of antigen detection